stockrowGuardant Health, Inc.
GH Healthcare Diagnostics & Research
Guardant Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $982.0 million, up 32.9% from fiscal 2024.
- Revenue
- +36.1%
- EPS
- −25.7%
- Free cash flow
- +18.7%
- Total debt
- +34.8%
Quarter to September 2026, against a year earlier
Follow GH
Alert me
Guardant Health, Inc. (GH) Debt to equity
Guardant Health, Inc.'s debt to equity at the end of the quarter to 30 September 2026 was −5.4×, up 9.7× from fiscal 2025 (−15.1×). Over the past ten years it has ranged from −15.1× (fiscal 2025) to 18.9× (fiscal 2022) — the current reading is the lowest in ten years. That is below the Diagnostics & Research industry median of 0.0× and below the Healthcare sector median of 0.0×.
Debt to equity, annual
Embed this chart
Annual newest first
| Period | Debt to equity | Change |
|---|---|---|
| FY2025 | −15.1× | — |
| FY2024 | −8.2× | — |
| FY2023 | 7.2× | (61.99%) |
| FY2022 | 18.9× | 974.22% |
| FY2021 | 1.8× | 183.36% |
| FY2020 | 0.6× | 1,139.32% |
| FY2019 | 0.1× | 245.52% |
| FY2018 | 0.0× | 866.67% |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | Debt to equity | Change |
|---|---|---|
| Sep 2026 | −5.4× | — |
| Jun 2026 | −6.7× | — |
| Mar 2026 | −8.3× | — |
| Dec 2025 | −15.1× | — |
| 33 more quarters | Free account |
Against its own ten years
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| GH Guardant Health, Inc. | −5.4× |
| MEDP Medpace Holdings, Inc. compare | 0.0× |
| RVTY Revvity Inc. compare | 0.4× |
| ICLR ICON PLC compare | 0.4× |
| ILMN Illumina, Inc. compare | 0.6× |
| LH Labcorp Holdings Inc. compare | 0.6× |
| DGX Quest Diagnostics Incorporated compare | 0.7× |
| CRL Charles River Laboratories International, Inc. compare | 0.8× |
| MTD Mettler-Toledo International, Inc. compare | 165× |
| Diagnostics & Research industry median | 0.0× |
| Healthcare sector median | 0.0× |
| Market median | 0.1× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on GH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement